Trumps Accused of Sourcing 'T1 Phone' From China Despite 'Built in the US' Claim: 'It's Simply Not Possible'
The Trump Organization unveiled its new T1 smartphone under the Trump Mobile brand, a device that claims to be "proudly designed and built in the United States."
However, analysts say the T1 bears a striking resemblance to Chinese-made phones already on the market, and could not have been domestically manufactured within the given timeframe.
"It's simply not possible," said Todd Weaver, CEO of Purism, one of the only companies to manufacture phones in the U.S. Speaking to CNN, Weaver added that the Trump family has not invested in the kind of fabrication infrastructure required to build a phone domestically.
"There are only realistically four or five smartphone [manufacturers] that could make this, and all of them are based out of China," tech analyst Max Weinbach told CNN.
Even Purism, which sells a $1,999 U.S.-assembled "Liberty Phone," admits it sources some components from abroad due to global supply chain limitations. "Just to manufacture a phone in the U.S. with the chipsets you're actually getting...is a massive undertaking," Weaver added, noting the stringent FTC guidelines required to claim "Made in the USA."
A TikTok video from tech creator Luke Miani was also dubious of the claims on Trump Mobile's website. He went through the website, highlighting basic errors in the spec sheet. "'Storage: 12GB of RAM.' That's not what storage is... '5,000mAh hour long life camera.' That? Okay. That's not how cameras work at all."
"I'm not going to suggest that they just went on to AliExpress and bought a phone," he said sarcastically, going to the website that listed the exact same specs. "They definitely did not just buy something almost exactly like this and mark it up ten times."
Weinbach identified the T1's specs—including its 6.8-inch display, triple camera setup, 5,000mAh battery, and even its headphone jack—as matching that of existing phones like the Revvl 7 Pro 5G, produced by China-based Wingtech. Another nearly identical device, the Vtex Smart Phone, is sold on Made-in-China.com.
President Donald Trump has threatened 25% tariffs on smartphones made overseas and pressured companies like Apple to shift production to the U.S. Although Don Jr. and Eric Trump have insisted their father is not involved in the Trump Organization, Trump Mobile's "Made in the USA" claim echoes the president's push to bring tech manufacturing back to the U.S. soil.
But industry experts say a September 2025 U.S. launch for a truly domestic smartphone remains infeasible. "The majority of any phone sold this fall will not be made in the U.S.," said Ryan Reith of IDC. "That's a given."
While no direct link to overseas manufacturers have been confirmed, skepticism of the phone's origins remain high. Eric Trump fueled existing doubt on Monday when he said, "Eventually all the Trump phones will be built in the USA" on a podcast, contradicting the website and formal announcement that explicitly stated "Made in the USA."
The admission didn't get past Miani. "According to the Trump Organization, these phones will ' eventually ' be made in America, even though no phone in the entire world currently is," Miani said on TikTok, his voice still laced in sarcasm. "So I believe them. I believe all of that."
Originally published on Latin Times
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Int'l Business Times
an hour ago
- Int'l Business Times
World Bank And IMF Climate Snub 'Worrying': COP29 Presidency
The hosts of the most recent UN climate talks are worried international lenders are retreating from their commitments to help boost funding for developing countries' response to global warming. This anxiety has grown as the Trump administration has slashed foreign aid and discouraged US-based development lenders like the World Bank and the International Monetary Fund from focussing on climate finance. Developing nations, excluding China, will need an estimated $1.3 trillion a year by 2035 in financial assistance to transition to renewable energy and climate-proof their economies from increasing weather extremes. But nowhere near this amount has been committed. At last year's UN COP29 summit in Azerbaijan, rich nations agreed to increase climate finance to $300 billion a year by 2035, an amount decried as woefully inadequate. Azerbaijan and Brazil, which is hosting this year's COP30 conference, have launched an initiative to plug the shortfall that includes expectations of "significant" contributions from international lenders. But so far only two -- the African Development Bank and the Inter-American Development Bank -- have responded to a call to engage the initiative with ideas, said COP29 president Mukhtar Babayev. "We call on their shareholders to urgently help us to address these concerns," he told climate negotiators at a high-level summit in the German city of Bonn this week. "We fear that a complex and volatile global environment is distracting" many of those expected to play a big role in bridging the climate finance gap, he added. His team travelled to Washington in April for the IMF and World Bank's spring meetings hoping to find the same enthusiasm for climate lending they had encountered a year earlier. But instead they found institutions "very much reluctant now to talk about climate at all", said Azerbaijan's top climate negotiator Yalchin Rafiyev. This was a "worrisome trend", he said, given expectations these lenders would extend the finance needed in the absence of other sources. "They're very much needed," he said. The United States, the World Bank's biggest shareholder, has sent a different message. On the sidelines of the April spring meetings, US Treasury Secretary Scott Bessent urged the bank to focus on "dependable technologies" rather than "distortionary climate finance targets." This could mean investing in gas and other fossil fuel-based energy production, he said. Under the Paris Agreement, wealthy developed countries -- those most responsible for global warming to date -- are obligated to pay climate finance to poorer nations. But other countries, most notably China, do make their own voluntary contributions. Finance is a source of long-running tensions at UN climate negotiations. Donors have consistently failed to deliver on past finance pledges, and committed well below what experts agree developing nations need to prepare for the climate crisis. The issue flared again this week in Bonn, with nations at odds over whether to debate financial commitments from rich countries during the formal meetings. European nations have also pared back their foreign aid spending in recent months, raising fears that budgets for climate finance could also face a haircut. At COP29, multilateral development banks (MDBs) led by the World Bank Group estimated they could provide $120 billion annually in climate financing to low and middle income countries, and mobilise another $65 billion from the private sector by 2030. Their estimate for high income countries was $50 billion, with another $65 billion mobilised from the private sector. Rob Moore, of policy think tank E3G, said these lenders are the largest providers of international public finance to developing countries. "Whilst they are facing difficult political headwinds in some quarters, they would be doing both themselves and their clients a disservice by disengaging on climate change," he said. The World Bank in particular has done "a huge amount of work" to align its lending with global climate goals. "If they choose to step back this would be at their own detriment, and other banks like the regionally based MDBs would likely play a bigger role in shaping the economy of the future," he said. The World Bank did not immediately respond to a request for comment.
Int'l Business Times
7 hours ago
- Int'l Business Times
Crude Sinks As Trump Delays Decision On Iran Strike
Oil prices tumbled Friday and equity traders fought to end a volatile week on a positive note after Donald Trump said he would consider over the next two weeks whether to join Israel's attacks on Iran. Speculation had been swirling that Trump would throw his lot in with Israel, but on Thursday he said he would decide "within the next two weeks" whether to involve the United States, giving diplomacy a shot to end the hostilities. While tensions are sky high amid fears of an escalation, the US president's remarks suggested the crisis could be prevented from spiralling into all-out war between the Middle East foes. Since Israel first hit Iran last Friday, the two have exchanged deadly strikes and apocalyptic warnings, though observers said the conflict has not seen a critical escalation. European foreign ministers were due to meet their Iranian counterpart on Friday in Geneva. In a statement read out by White House Press Secretary Karoline Leavitt, the president said: "Based on the fact that there's a substantial chance of negotiations that may or may not take place with Iran in the near future, I will make my decision whether or not to go within the next two weeks." Leavitt added: "If there's a chance for diplomacy the president's always going to grab it, but he's not afraid to use strength as well." Both main oil contracts were down around two percent Friday but uncertainty prevailed and traders remained nervous. "Crude still calls the shots, and volatility's the devil in the room -- and every trader on the street knows we're two headlines away from chaos," said Stephen Innes at SPI Asset Management. "Make no mistake: we're trading a geopolitical powder keg with a lit fuse. "President Trump's two-week 'thinking window' on whether to join Israel's war against Iran is no cooling-off period -- it's a ticking volatility clock." Stocks were mixed following a public holiday in New York, with Hong Kong, Taipei, Mumbai and Bangkok all up with London, Paris and Frankfurt. Seoul's Kospi led the gains, rising more than one percent to break 3,000 points for the first time in nearly three and a half years. The index has risen every day except one since the June 4 election of a new president, which ended months of political crisis and fuelled hopes for an economic rebound. Tokyo fell as Japanese core inflation accelerated, stoked by a doubling in the cost of rice, a hot topic issue that poses a threat to Prime Minister Shigeru Ishiba ahead of elections next month. There were also losses in Shanghai, Sydney, Singapore, Manila and Jakarta. The Middle East crisis continues to absorb most of the news but Trump's trade war remains a major obstacle for investors as the end of a 90-day pause on his April 2 tariff blitz approaches with few governments reaching deals to avert them being imposed. "While the worst of the tariffs have been paused, we suspect it won't be until those deadlines approach that new agreements may be finalised," said David Sekera, chief US market strategist at Morningstar. "Until then, as news emerges regarding the progress and substance of trade negotiations, these headlines could have an outsize positive or negative impact on markets." Brent North Sea Crude: DOWN 2.6 percent at $76.85 per barrel West Texas Intermediate: DOWN 1.9 percent at $73.62 per barrel Tokyo - Nikkei 225: DOWN 0.2 percent at 38,403.23 (close) Hong Kong - Hang Seng Index: UP 0.8 percent at 23,421.80 Shanghai - Composite: DOWN 0.1 percent at 3,359.90 (close) London - FTSE 100: UP 0.3 percent at 8,819.26 Euro/dollar: UP at $1.1517 from $1.1463 on Thursday
Int'l Business Times
7 hours ago
- Int'l Business Times
EU Bars Chinese Firms From Major State Medical Equipment Contracts
The European Union on Friday banned Chinese firms from government medical device purchases worth more than five million euros ($5.8 million) in retaliation for limits Beijing places on access to its own market. The latest salvo in trade tensions between the 27-nation bloc and China covers a wide range of healthcare supplies, from surgical masks to X-ray machines, that represent a market worth 150 billion euros in the EU. "Our aim with these measures is to level the playing field for EU businesses," the bloc's trade commissioner Maros Sefcovic said. "We remain committed to dialogue with China to resolve these issues." In response, China accused the EU of "double standards". "The EU has always boasted that it is the most open market in the world, but in reality, it has gradually moved towards protectionism", foreign ministry spokesman Guo Jiakun said at a regular press briefing. "Under the guise of fair competition (the EU) actually carries out unfair competition, which is a typical case of double standards." The European Commission said in a statement the move was in "response to China's longstanding exclusion of EU-made medical devices from Chinese government contracts." Brussels said just under 90 percent of public procurement contracts for medical devices in China "were subject to exclusionary and discriminatory measures" against EU firms. In addition to barring Chinese firms from major state purchases, "inputs from China for successful bids" would also be limited to 50 percent, it said. Over the last three years, Brussels and Beijing have come into conflict in a number of economic sectors, including electric cars, the rail industry, solar panels and wind turbines. The decision on medical devices comes at a time of heightened trade tensions with President Donald Trump's United States, which has imposed customs surcharges on imports from all over the world, including Europe. The EU has decided to take a tougher stance on trade in recent years, adopting a vast arsenal of legislation to better defend its businesses against unfair competition. In April 2024, the commission opened an investigation into Chinese public contracts for medical devices, the first under a new mechanism introduced by the EU in 2022 to obtain better access to overseas state purchases. China, on the other hand, accuses Europe of protectionism. After a year of negotiations, the commission, which manages trade policy on behalf of the 27 member states, said it had failed to make any progress with China. "The measure seeks to incentivise China to cease its discrimination against EU firms and EU-made medical devices and treat EU companies with the same openness as the EU does with Chinese companies and products," Brussels said.
